Generated by GPT-5-mini| J & J | |
|---|---|
| Name | J & J |
| Type | Public |
| Industry | Pharmaceuticals; Consumer Goods; Medical Devices |
| Founded | 1886 |
| Founder | Robert Wood Johnson; James Wood Johnson; Edward Mead Johnson |
| Headquarters | New Brunswick, New Jersey |
| Key people | Joaquin Duato; Michael Sneed |
| Revenue | US$ 82.6 billion (2023) |
| Employees | ~152,700 (2023) |
J & J is a multinational corporation operating in pharmaceuticals, medical devices, and consumer health products. It has grown from a 19th‑century family business into a global conglomerate with divisions spanning research, manufacturing, and retail distribution. The company has been involved with major acquisitions, regulatory approvals, global public health efforts, and high‑profile litigation.
J & J traces origins to the late 19th century when founders Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson established a shop in New Brunswick, New Jersey to produce sterile surgical dressings. Early milestones included the introduction of the Johnson's Baby Powder brand and expansion into antiseptics and bandages. In the 20th century the firm diversified through internal development and acquisitions, interacting with entities such as McNeil Consumer Healthcare and Cordis Corporation. During World War II the company supplied medical products to armed forces allied with the United States and cooperated with institutions like the National Institutes of Health on wartime medical research. Postwar growth involved globalization into markets across Europe, Asia, and Latin America, with manufacturing sites near hubs such as Belgium, Ireland, and Singapore. Strategic moves in the late 20th and early 21st centuries included acquisitions of pharmaceutical and device makers, cooperation with pharmaceutical partners like Merck and Pfizer on research programs, and listings on the New York Stock Exchange.
J & J operates through major segments that include pharmaceuticals, medical devices, and consumer health. The pharmaceuticals segment develops drug candidates targeting indications formerly addressed by companies such as Janssen Biotech and operates research alliances with academic centers like Harvard Medical School and Johns Hopkins University. The medical devices business encompasses implants and surgical systems influenced by technologies from firms like DePuy Synthes and Ethicon, and sells into hospital systems such as Mayo Clinic and Cleveland Clinic. The consumer health arm distributes brands found in retailers including Walmart, Target, and CVS Health. Manufacturing and supply chains extend to contract manufacturers and regulators including Food and Drug Administration and European Medicines Agency. Corporate operations coordinate with investment banks and governance institutions such as Goldman Sachs and engage in mergers and divestitures under review by competition authorities including the Federal Trade Commission and the European Commission.
J & J's consumer portfolio includes legacy brands across infant care, skincare, and hygiene with market presence comparable to companies like Procter & Gamble and Unilever. In pharmaceuticals the company markets therapies developed by subsidiaries including Janssen Pharmaceutical Companies, spanning immunology, oncology, and infectious disease with approvals filed at agencies such as the FDA and marketed globally through distributors including McKesson Corporation. Medical devices span orthopedics, interventional cardiology, and surgical systems; some product lines trace heritage to acquisitions of firms like DePuy and Cordis. The company also provides clinical services and collaborates with hospitals such as Johns Hopkins Hospital and Massachusetts General Hospital on real‑world evidence programs and post‑market surveillance.
Governance at J & J follows a board‑driven model with committees overseeing audit, compensation, and risk, drawing directors with backgrounds from institutions like Princeton University, Harvard Business School, and corporations such as IBM and ExxonMobil. Executive leadership has included chief executives and chairpersons experienced in global healthcare markets, with succession planning coordinated by institutional investors such as Vanguard and BlackRock. The company maintains codes of conduct and compliance programs addressing anti‑corruption rules enforced by agencies like the Department of Justice and coordinates public filings with the Securities and Exchange Commission.
J & J has faced multiple high‑profile legal matters involving product liability, patent disputes, and regulatory enforcement. Notable litigation concerns allege harms related to talc products, surgical implants, and opioid distribution; cases have been litigated in federal and state courts including venues in New Jersey and Missouri. The company has been involved in settlement negotiations with plaintiffs represented by law firms and oversight by judges from courts such as the United States District Court for the District of New Jersey. Antitrust reviews have examined acquisitions in markets regulated by the European Commission and the Federal Trade Commission. Regulatory inspections by the FDA and investigations by agencies like the Department of Justice have prompted remediation programs, recalls, and changes to manufacturing practices.
J & J conducts global public health initiatives, partnering with organizations such as the World Health Organization, Gavi, the Vaccine Alliance, and UNICEF on vaccination, maternal and child health, and emergency response programs. Philanthropic efforts include grants to universities like Columbia University and University of Pennsylvania for medical research, collaborations with non‑profits such as Bill & Melinda Gates Foundation, and employee engagement through corporate volunteer programs tied to relief efforts after events like Hurricane Katrina and the COVID‑19 pandemic. Sustainability reporting aligns with frameworks from bodies such as the Global Reporting Initiative and the company participates in industry coalitions including the Pharmaceutical Research and Manufacturers of America.
Category:Multinational corporations Category:Pharmaceutical companies of the United States Category:Medical device manufacturers